SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-076309
Filing Date
2022-06-30
Accepted
2022-06-30 16:13:16
Documents
12
Period of Report
2022-06-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2220044d1_8k.htm   iXBRL 8-K 39254
  Complete submission text file 0001104659-22-076309.txt   212834

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA knsa-20220629.xsd EX-101.SCH 3030
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE knsa-20220629_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knsa-20220629_pre.xml EX-101.PRE 22593
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2220044d1_8k_htm.xml XML 3611
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 221058178
SIC: 2834 Pharmaceutical Preparations